EasyManua.ls Logo

AbbVie Duodopa - Important Information and Warnings

Default Icon
32 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
11
EDUCATIONAL MATERIAL FOR RISK MINIMISATION
Important Information
Duodopa
®
, 20 mg/mL + 5 mg/mL, intestinal gel
levodopa and carbidopa monohydrate
Read all of this information carefully before you start
taking this medicine.
If you have any further questions, ask your doctor, pharmacist
or nurse� Additional information is also provided in the patient
information leaet.
This medicine has been prescribed for you� Do not pass
it on to others� It may harm them, even if their symptoms
are the same as yours�
If you get any side effects, talk to your doctor, pharmacist or
nurse� This includes any possible side effects not listed in this
patient information leaet or pocket guide.
If your PEG-J tube becomes kinked, knotted, or blocked
this may cause you to have worsening of your Parkinson’s
symptoms or recurring movement problems (motor
uctuations). Call your doctor or nurse if your Parkinson’s
symptoms get worse or you have slow movement while you
are treated with Duodopa
®